HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

MONRATE: A descriptive tool for calculation and prediction of re-infection of Ascaris lumbricoides (Ascaridida: Ascarididae).

Abstract
The study presents an interactive descriptive tool (MONRATE) for calculating and predicting reinfection rates and time of Ascaris lumbricoides following mass chemotherapy. The implementation was based on the theoretical equation published by Hayashi in 1977, for time-prevalence: Y=G [1-(1-X)(N-R)] as modified by Jong-Yil in 1983. Using the Psuedo-Code of the MONRATE tool, the calculated monthly reinfection rates (X) for the LGAs are (names are locations in Nigeria in a region predominately populated by the Yoruba speaking tribes of Nigeria whose traditional occupations are agriculture and commerce): Ewekoro (1.6%), Odeda (2.3%), Ado-odo/Otta (2.3%), Ogun Waterside (3.8%) and Obafemi/Owode (4.2%). The mathematical mean of 'X' values in the study areas for Ogun State was 2.84. The calculated reinfection time (N months) for the LGAs are varied such as Ado-odo/Otta (12.7), Ogun Waterside (21.8), Obafemi/Owode (22.92), Odeda (25.45), and Ewekoro (25.9). The mean value for N in Ogun State was 21.75. The results obtained from MONRATE were compared with those obtained using the mathematical equation and found to be the same.
AuthorsS O Sam-Wobo, C F Mafiana, S A Onashoga, O R Vincent
JournalRevista de biologia tropical (Rev Biol Trop) 2007 Sep-Dec Vol. 55 Issue 3-4 Pg. 755-60 ISSN: 0034-7744 [Print] Costa Rica
PMID19086380 (Publication Type: Journal Article)
Chemical References
  • Antinematodal Agents
  • Levamisole
Topics
  • Adolescent
  • Animals
  • Antinematodal Agents (therapeutic use)
  • Ascariasis (drug therapy, epidemiology)
  • Ascaris lumbricoides (isolation & purification)
  • Child
  • Feces (parasitology)
  • Female
  • Humans
  • Intestinal Diseases, Parasitic (drug therapy, epidemiology)
  • Levamisole (therapeutic use)
  • Male
  • Nigeria (epidemiology)
  • Prevalence
  • Probability
  • Recurrence
  • Severity of Illness Index
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: